Skip to main content
Premium Trial:

Request an Annual Quote

Bionano Genomics, Hamilton Partner on Automated Ultra-High Molecular Weight DNA Extraction

NEW YORK — Bionano Genomics and Hamilton said on Thursday that they have partnered on the development of an automated system for the extraction of ultra-high molecular weight (UHMW) DNA for use in optical genome mapping (OGM).

Called Long String Vantage, the workstation supports the extraction of UHMW DNA at increased scale, the companies said. Running the Bionano Prep SP Blood and Cell Culture DNA Isolation Kit, the system can obtain UHMW DNA from up to 12 samples in less than four hours with high consistency and reproducibility.

Bionano and Hamilton said they plan to work with select clinical research labs to test and further develop applications for the Long String Vantage workstation with Bionano's sample prep kits, with initial workflows slated for commercial release later this year.

In January, Hamilton, which is based out of Nevada and Switzerland, announced it has been collaborating with Pacific Biosciences on the development of an automated solution for PacBio's Circulomics high molecular weight DNA sample prep product.

Last month, San Diego-based Bionano detailed its strategy for advancing OGM into clinical practice and said it is preparing to introduce the next version if its OGM instrument.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.